Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Steritas
Concord, Massachusetts, United Statessteritas.com ↗
- Ownership
- Private
- Employees
- ~41
- Development stage
- Other
01
Overview
Steritas’s STOX Suite is the first validated system for measuring steroid-toxicity, broadly adopted globally in clinical trials and at the point of care; data from >1100 sites in 80+ countries, 25+ indications; supports drug development for steroid-sparing therapeutics
- Therapeutic areas
- ImmunologyNephrologyOphthalmologyPsychiatryInfectious DiseasesRare DiseasesDermatologyNeurologyWomen's Health
- Modalities
- Digital clinical outcome assessment
- Industry
- Digital Health Medical Devices
02
Partnerships
argenx (Immunology therapeutics; STOX Suite used across argenx’s immunology clinical trials for steroid-sparing therapies)
Beyond the preview
Go deeper on Steritas.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Steritas.